Sjögren Syndrome Prevalent Among Pediatric Patients With Recurrent Parotitis
Researchers aimed to characterize prevalence of Sjögren syndrome among children with recurrent parotitis.
Sjogren Syndrome
Symptom-Based Stratification Reveals Pathobiologic Endotypes With Distinct Treatment Responses in Sjogren Syndrome
Researchers aimed to develop a stratification method to evaluate symptom prevalence and distinct treatment responses in patients with Sjogren syndrome.
Gout Increases Risk for Sjogren Syndrome in Older Adults
Gout was linked to a 1.7-fold increased risk for incident Sjogren syndrome in adults older than 65 years.
Lymphoma Associated With High Parotid Uptake and Pulmonary Lesions on PET-CT in Primary Sjogren Syndrome
A lymphoma diagnosis was associated with focal lung lesions or maximum parotid gland uptake on PET-CT in primary Sjogren syndrome.
Smoking Status Inversely Linked to Primary Sjogren Syndrome
Data show that current smoking status was inversely associated with primary Sjogren syndrome.
Phosphatidylinositol 3-Kinase Delta: A Potential Target Pathway in Sjogren Syndrome
Data show that the phosphatidylinositol 3-kinase delta isoform pathway is active in Sjogren syndrome.
Rheumatic Disease Risk Increased in Myasthenia Gravis After Thymectomy
Data revealed an association between myasthenia gravis and autoimmune rheumatic diseases.
B-Cell Biomarkers Linked to Disease Activity Indicators in Primary Sjogren Syndrome
Three biomarkers related to B-cell activity were associated with various domains of the European League Against Rheumatism Sjogren Syndrome Disease Activity Index.
Expert Insight: A Closer Look at Neurological Manifestations of Sjogren Syndrome
Experts discuss the symptoms and prevalence of neurological manifestations in Sjogren syndrome.
Epratuzumab in SLE With Associated Sjogren Syndrome Improved SLE Disease Activity
Epratuzumab improved systemic lupus erythematosus disease activity in patients with associated Sjogren syndrome.
Next post in Systemic Lupus Erythematosus
